Literature DB >> 17383417

Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis.

Ralf Kiesslich1, Martin Goetz, Katharina Lammersdorf, Constantin Schneider, Juergen Burg, Manfred Stolte, Michael Vieth, Bernhard Nafe, Peter R Galle, Markus F Neurath.   

Abstract

BACKGROUND AND AIMS: Because of the large number of biopsy specimens, surveillance colonoscopy in ulcerative colitis (UC) is currently time consuming and significant flat lesions still may be missed. In this study we assessed the value of combined chromoscopy and endomicroscopy for the diagnosis of intraepithelial neoplasias in a randomized controlled trial.
METHODS: A total of 161 patients with long-term UC in clinical remission were randomized at a 1:1 ratio to undergo conventional colonoscopy or chromoscopy with endomicroscopy. Eight patients were excluded because of insufficient bowel preparation. In the conventional colonoscopic group (n = 73), random biopsy examinations and targeted biopsy examinations were performed. In the endomicroscopy group (n = 80), circumscribed mucosal lesions were identified by chromoscopy and evaluated for targeted biopsy examination by endomicroscopy. The primary outcome analysis was based on the detection of neoplasias.
RESULTS: By using chromoscopy with endomicroscopy, 4.75-fold more neoplasias could be detected (P = .005) than with conventional colonoscopy, although 50% fewer biopsy specimens (P = .008) were required. If only circumscribed lesions would have been biopsied in the first group, the total number of biopsy specimens could have been reduced by more than 90%. A total of 5580 confocal endomicroscopic images from 134 circumscribed lesions were compared with histologic results. The presence of neoplastic changes could be predicted by endomicroscopy with high accuracy (sensitivity, 94.7%; specificity, 98.3%; accuracy, 97.8%).
CONCLUSIONS: Endomicroscopy based on in vivo histology can determine if UC lesions identified by chromoscopy should undergo biopsy examination, thereby increasing the diagnostic yield and reducing the need for biopsy examinations. Thus, chromoscopy-guided endomicroscopy may lead to significant improvements in the clinical management of UC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383417     DOI: 10.1053/j.gastro.2007.01.048

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  126 in total

1.  Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols.

Authors:  Ute Günther; Dajana Kusch; Frank Heller; Nataly Bürgel; Silke Leonhardt; Severin Daum; Britta Siegmund; Christoph Loddenkemper; Maria Grünbaum; Heinz-Johannes Buhr; Jörg-Dieter Schulzke; Martin Zeitz; Christian Bojarski
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

2.  Endoscopic imaging: How far are we from real-time histology?

Authors:  Richa Shukla; Wasif M Abidi; Rebecca Richards-Kortum; Sharmila Anandasabapathy
Journal:  World J Gastrointest Endosc       Date:  2011-10-16

3.  [Advances in endoscopic diagnosis of dysplasia and carcinoma of the larynx].

Authors:  C Arens; U Vorwerk; T Just; C S Betz; M Kraft
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

4.  Endoscopy in inflammatory bowel disease when and why.

Authors:  Rajaratnam Rameshshanker; Naila Arebi
Journal:  World J Gastrointest Endosc       Date:  2012-06-16

5.  Random versus targeted biopsies for colorectal cancer surveillance in inflammatory bowel disease.

Authors:  Tasneem Ahmed; Jennifer Monti; Bret Lashner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-07

6.  Screening: Endomicroscopy for a reliable diagnosis of colorectal neoplasia.

Authors:  Ralf Kiesslich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08       Impact factor: 46.802

7.  Evaluation of quantitative image analysis criteria for the high-resolution microendoscopic detection of neoplasia in Barrett's esophagus.

Authors:  Timothy J Muldoon; Nadhi Thekkek; Darren Roblyer; Dipen Maru; Noam Harpaz; Jonathan Potack; Sharmila Anandasabapathy; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

8.  Is chromoendoscopy the new standard for cancer surveillance in patients with ulcerative colitis?

Authors:  Markus F Neurath; Ralf Kiesslich
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-01-27

9.  Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients.

Authors:  Stefano Scaringi; Carmela Di Martino; Daniela Zambonin; Marilena Fazi; Giuseppe Canonico; Francesca Leo; Ferdinando Ficari; Francesco Tonelli
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

Review 10.  Indications, stains and techniques in chromoendoscopy.

Authors:  P J Trivedi; B Braden
Journal:  QJM       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.